BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 33866000)

  • 1. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.
    Kadali RAK; Janagama R; Peruru S; Malayala SV
    Int J Infect Dis; 2021 May; 106():376-381. PubMed ID: 33866000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.
    Kadali RAK; Janagama R; Peruru S; Gajula V; Madathala RR; Chennaiahgari N; Malayala SV
    J Med Virol; 2021 Jul; 93(7):4420-4429. PubMed ID: 33822361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
    Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH
    J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
    Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S
    J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
    Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR
    J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of messenger RNA vaccines and prior history of COVID-19, a cross-sectional study.
    Kadali RAK; Janagama R; Yedlapati SH; Kanike N; Gajula V; Madathala RR; Poddar S; Sukka N; Jogu HR; Racherla S; Shah I
    Am J Infect Control; 2022 Jan; 50(1):8-14. PubMed ID: 34718069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.
    Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan.
    Saita M; Yan Y; Ito K; Sasano H; Seyama K; Naito T
    J Infect Chemother; 2022 Jan; 28(1):116-119. PubMed ID: 34580011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and side effect profile of Pfizer-BioNTech COVID-19 vaccination among healthcare workers: A tertiary hospital experience in Singapore.
    Lim SM; Chan HC; Santosa A; Quek SC; Liu EHC; Somani J
    Ann Acad Med Singap; 2021 Sep; 50(9):703-711. PubMed ID: 34625758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
    Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
    Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers.
    Lee DY; Kang DY; Kim E; Lee SJ; Baek JH; Lee JS; Park MY; Im JH
    Medicine (Baltimore); 2023 Mar; 102(11):e33236. PubMed ID: 36930126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccine.
    Borroni E; Consonni D; Cugno M; Lombardi A; Mangioni D; Bono P; Oggioni M; Uceda Renteria S; Bordini L; Nava CD; Letzgus M; Gentiloni Silverj F; Castaldi S; Rognoni M; Cavallieri D'Oro L; Carugno M; Riboldi L; Ceriotti F; Bandera A; Gori A; Pesatori AC
    Med Lav; 2021 Dec; 112(6):477-485. PubMed ID: 34939617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency Department Utilization by In-hospital Healthcare Workers after COVID-19 Vaccination.
    Park MJ; Choi YJ; Choi S
    J Korean Med Sci; 2021 Jul; 36(27):e196. PubMed ID: 34254475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review.
    Dighriri IM; Alhusayni KM; Mobarki AY; Aljerary IS; Alqurashi KA; Aljuaid FA; Alamri KA; Mutwalli AA; Maashi NA; Aljohani AM; Alqarni AM; Alfaqih AE; Moazam SM; Almutairi MN; Almutairi AN
    Cureus; 2022 Mar; 14(3):e23526. PubMed ID: 35494952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events following BNT162b2 mRNA COVID-19 vaccination among healthcare workers: A single-centre experience in Malaysia.
    Gan LL; Zahidah AR; Hazirah T; Nabilah HK; Aisyah Z; Amin INM; Ng DCE
    Med J Malaysia; 2022 May; 77(3):300-305. PubMed ID: 35638485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
    Hassan YAM; Daud Ali M; Al-Eid RR; Al-Ghuraya FA; Essa Alqasimi Z; Ahmad A; Eltrafi Z; Ghosn SA
    Vaccine; 2022 Nov; 40(49):7087-7096. PubMed ID: 36404426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Events Following BNT162b2 mRNA COVID-19 Vaccine Immunization among Healthcare Workers in a Tertiary Hospital in Johor, Malaysia.
    Tan AY; Chang CT; Yu YK; Low YX; Razali NFM; Tey SY; Lee SWH
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.